231 companies

Alnylam Pharmaceuticals

Market Cap: US$33.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$259.39

7D

3.1%

1Y

70.3%

AVITA Medical

Market Cap: US$244.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$9.24

7D

-8.2%

1Y

5.6%

Travere Therapeutics

Market Cap: US$1.9b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TVTX

US$21.15

7D

15.4%

1Y

237.9%

TG Therapeutics

Market Cap: US$6.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

TGTX

US$43.44

7D

5.1%

1Y

168.3%

Lumentum Holdings

Market Cap: US$4.3b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

LITE

US$62.86

7D

4.8%

1Y

40.5%

Ascendis Pharma

Market Cap: US$10.4b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$172.06

7D

4.8%

1Y

25.4%

Alkami Technology

Market Cap: US$2.8b

Provides cloud-based digital banking solutions in the United States.

ALKT

US$26.99

7D

0.4%

1Y

-1.2%

Arcutis Biotherapeutics

Market Cap: US$1.8b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

ARQT

US$15.24

7D

4.3%

1Y

90.5%

Super Micro Computer

Market Cap: US$20.1b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

SMCI

US$33.71

7D

-7.6%

1Y

-56.9%

Clene

Market Cap: US$25.7m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

CLNN

US$2.98

7D

-0.7%

1Y

-65.7%

Alvotech

Market Cap: US$2.5b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$8.22

7D

3.5%

1Y

-42.9%

Core Scientific

Market Cap: US$2.6b

Provides digital asset mining services in the United States.

CORZ

US$8.74

7D

5.2%

1Y

160.9%

Blueprint Medicines

Market Cap: US$6.8b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$104.64

7D

19.4%

1Y

-2.4%

Applied Optoelectronics

Market Cap: US$830.5m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$14.96

7D

19.1%

1Y

35.1%

CoreWeave

Market Cap: US$23.9b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

CRWV

US$51.57

7D

24.1%

1Y

n/a

Red Cat Holdings

Market Cap: US$538.1m

Provides products and solutions to drone industry in the United States.

RCAT

US$5.95

7D

14.5%

1Y

426.1%

Palantir Technologies

Market Cap: US$293.3b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$124.28

7D

10.2%

1Y

432.7%

Bitdeer Technologies Group

Market Cap: US$2.2b

Operates as a technology company for blockchain and computing.

BTDR

US$10.97

7D

4.2%

1Y

91.1%

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$33.17

7D

-3.2%

1Y

-27.0%

Duos Technologies Group

Market Cap: US$79.6m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

DUOT

US$6.91

7D

3.2%

1Y

124.9%

Vanda Pharmaceuticals

Market Cap: US$269.3m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.57

7D

7.5%

1Y

-6.4%

SpringWorks Therapeutics

Market Cap: US$3.4b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

SWTX

US$46.23

7D

3.4%

1Y

2.5%

MeiraGTx Holdings

Market Cap: US$571.7m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

MGTX

US$7.25

7D

8.2%

1Y

45.0%

TruGolf Holdings

Market Cap: US$12.6m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

TRUG

US$0.29

7D

-7.8%

1Y

-81.8%

Madrigal Pharmaceuticals

Market Cap: US$7.0b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$315.48

7D

-3.5%

1Y

37.3%

RenovoRx

Market Cap: US$36.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.00

7D

1.0%

1Y

-18.0%

Tenaya Therapeutics

Market Cap: US$84.6m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TNYA

US$0.52

7D

5.9%

1Y

-88.9%

Roadzen

Market Cap: US$65.3m

Operates as an insurance technology company.

RDZN

US$0.88

7D

-3.4%

1Y

-80.4%

UroGen Pharma

Market Cap: US$530.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$11.51

7D

16.6%

1Y

-19.5%

Smith Micro Software

Market Cap: US$18.7m

Develops and sells software solutions to simplify and enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.

SMSI

US$1.05

7D

-10.3%

1Y

-55.1%

Spotify Technology

Market Cap: US$132.1b

Provides audio streaming subscription services worldwide.

SPOT

US$644.00

7D

3.8%

1Y

117.5%

ARS Pharmaceuticals

Market Cap: US$1.4b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$14.46

7D

5.0%

1Y

48.3%

Nutanix

Market Cap: US$19.3b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

NTNX

US$72.54

7D

8.0%

1Y

16.5%

OS Therapies

Market Cap: US$44.2m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$2.04

7D

27.5%

1Y

n/a

SideChannel

Market Cap: US$11.0m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

SDCH

US$0.049

7D

19.4%

1Y

-17.5%

Similarweb

Market Cap: US$632.0m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

SMWB

US$7.63

7D

-1.4%

1Y

2.0%

Page 1 of 7